argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
815.61
+2.66 (0.33%)
At close: Oct 15, 2025, 4:00 PM EDT
822.00
+6.39 (0.78%)
After-hours: Oct 15, 2025, 4:48 PM EDT
argenx SE Market Cap
argenx SE has a market cap or net worth of $49.95 billion as of October 15, 2025. Its market cap has increased by 55.82% in one year.
Market Cap
49.95B
Enterprise Value
46.10B
1-Year Change
55.82%
Ranking
Category
Stock Price
$815.61
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $49.95B, an increase of 7,982.68%. That is a compound annual growth rate of 68.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 49.62B | 34.92% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |